vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Koppers Holdings Inc. (KOP). Click either name above to swap in a different company.
Koppers Holdings Inc. is the larger business by last-quarter revenue ($432.7M vs $284.0M, roughly 1.5× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 6.9%, a 89.5% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -9.3%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -6.7%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Koppers is a global chemical and materials company based in Pittsburgh, Pennsylvania, United States. Its headquarters is an art-deco 1920s skyscraper, the Koppers Tower.
ACAD vs KOP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $432.7M |
| Net Profit | $273.6M | $29.7M |
| Gross Margin | 90.8% | 25.6% |
| Operating Margin | 6.1% | 11.5% |
| Net Margin | 96.3% | 6.9% |
| Revenue YoY | 9.4% | -9.3% |
| Net Profit YoY | 90.3% | 391.2% |
| EPS (diluted) | $1.61 | $1.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $432.7M | ||
| Q3 25 | $278.6M | $485.3M | ||
| Q2 25 | $264.6M | $504.8M | ||
| Q1 25 | $244.3M | $456.5M | ||
| Q4 24 | $259.6M | $477.0M | ||
| Q3 24 | $250.4M | $554.3M | ||
| Q2 24 | $242.0M | $563.2M | ||
| Q1 24 | $205.8M | $497.6M |
| Q4 25 | $273.6M | $29.7M | ||
| Q3 25 | $71.8M | $23.8M | ||
| Q2 25 | $26.7M | $16.4M | ||
| Q1 25 | $19.0M | $-13.9M | ||
| Q4 24 | $143.7M | $-10.2M | ||
| Q3 24 | $32.8M | $22.8M | ||
| Q2 24 | $33.4M | $26.8M | ||
| Q1 24 | $16.6M | $13.0M |
| Q4 25 | 90.8% | 25.6% | ||
| Q3 25 | 92.2% | 24.1% | ||
| Q2 25 | 92.2% | 22.6% | ||
| Q1 25 | 91.7% | 23.2% | ||
| Q4 24 | 91.6% | 17.5% | ||
| Q3 24 | 92.5% | 21.9% | ||
| Q2 24 | 92.5% | 21.6% | ||
| Q1 24 | 88.8% | 19.3% |
| Q4 25 | 6.1% | 11.5% | ||
| Q3 25 | 12.8% | 10.7% | ||
| Q2 25 | 12.2% | 7.7% | ||
| Q1 25 | 7.9% | 5.9% | ||
| Q4 24 | 59.1% | 1.3% | ||
| Q3 24 | 12.6% | 9.0% | ||
| Q2 24 | 12.6% | 10.2% | ||
| Q1 24 | 7.4% | 7.0% |
| Q4 25 | 96.3% | 6.9% | ||
| Q3 25 | 25.8% | 4.9% | ||
| Q2 25 | 10.1% | 3.2% | ||
| Q1 25 | 7.8% | -3.0% | ||
| Q4 24 | 55.4% | -2.1% | ||
| Q3 24 | 13.1% | 4.1% | ||
| Q2 24 | 13.8% | 4.8% | ||
| Q1 24 | 8.0% | 2.6% |
| Q4 25 | $1.61 | $1.44 | ||
| Q3 25 | $0.42 | $1.17 | ||
| Q2 25 | $0.16 | $0.81 | ||
| Q1 25 | $0.11 | $-0.68 | ||
| Q4 24 | $0.86 | $-0.47 | ||
| Q3 24 | $0.20 | $1.09 | ||
| Q2 24 | $0.20 | $1.25 | ||
| Q1 24 | $0.10 | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | — |
| Total DebtLower is stronger | — | $928.3M |
| Stockholders' EquityBook value | $1.2B | $574.0M |
| Total Assets | $1.6B | $1.9B |
| Debt / EquityLower = less leverage | — | 1.62× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | — | ||
| Q2 24 | $177.1M | — | ||
| Q1 24 | $204.7M | — |
| Q4 25 | — | $928.3M | ||
| Q3 25 | — | $932.9M | ||
| Q2 25 | — | $977.5M | ||
| Q1 25 | — | $989.0M | ||
| Q4 24 | — | $939.5M | ||
| Q3 24 | — | $989.4M | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | — | $877.6M |
| Q4 25 | $1.2B | $574.0M | ||
| Q3 25 | $917.3M | $545.6M | ||
| Q2 25 | $822.4M | $526.8M | ||
| Q1 25 | $765.2M | $498.0M | ||
| Q4 24 | $732.8M | $488.7M | ||
| Q3 24 | $577.2M | $532.3M | ||
| Q2 24 | $516.7M | $509.2M | ||
| Q1 24 | $464.0M | $505.8M |
| Q4 25 | $1.6B | $1.9B | ||
| Q3 25 | $1.3B | $1.9B | ||
| Q2 25 | $1.2B | $1.9B | ||
| Q1 25 | $1.1B | $1.9B | ||
| Q4 24 | $1.2B | $1.9B | ||
| Q3 24 | $976.9M | $2.0B | ||
| Q2 24 | $914.1M | $1.9B | ||
| Q1 24 | $855.1M | $1.8B |
| Q4 25 | — | 1.62× | ||
| Q3 25 | — | 1.71× | ||
| Q2 25 | — | 1.86× | ||
| Q1 25 | — | 1.99× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | — | 1.97× | ||
| Q1 24 | — | 1.74× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $45.1M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 6.6% |
| Capex IntensityCapex / Revenue | — | 3.8% |
| Cash ConversionOCF / Net Profit | -0.18× | 1.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $67.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $45.1M | ||
| Q3 25 | $74.3M | $49.6M | ||
| Q2 25 | $64.0M | $50.5M | ||
| Q1 25 | $20.3M | $-22.7M | ||
| Q4 24 | $40.4M | $74.7M | ||
| Q3 24 | $63.2M | $29.8M | ||
| Q2 24 | $25.0M | $27.2M | ||
| Q1 24 | $29.1M | $-12.3M |
| Q4 25 | — | $28.5M | ||
| Q3 25 | $73.9M | $37.6M | ||
| Q2 25 | — | $38.4M | ||
| Q1 25 | — | $-37.0M | ||
| Q4 24 | — | $56.1M | ||
| Q3 24 | $63.2M | $14.4M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $-38.6M |
| Q4 25 | — | 6.6% | ||
| Q3 25 | 26.5% | 7.7% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | -8.1% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | 25.2% | 2.6% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | -7.8% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | 0.1% | 2.5% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | 0.0% | 2.8% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 5.3% |
| Q4 25 | -0.18× | 1.52× | ||
| Q3 25 | 1.03× | 2.08× | ||
| Q2 25 | 2.40× | 3.08× | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | 1.31× | ||
| Q2 24 | 0.75× | 1.01× | ||
| Q1 24 | 1.76× | -0.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
KOP
| Other | $127.8M | 30% |
| Railroad Treated Products | $119.0M | 28% |
| Utility Poles | $79.8M | 18% |
| Pitch And Related Products | $74.1M | 17% |
| Carbon Black Feedstock And Distillates | $14.4M | 3% |
| Railroad Infrastructure Products And Services | $9.9M | 2% |
| Phthalic Anhydride Naphthalene And Other Chemicals | $7.7M | 2% |
